Friday 6 November 2026 Export AUPH’s income statement to Excel — free account

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024.

Revenue: +13.9%
EPS: 0.00%
Free cash flow: +4.41%
Total debt: −30.0%

Quarter to September 2026, against a year earlier

16.40 0.19 +1.17%

Follow AUPH

Alert me

Market cap: $2.2B
P/E: 6.8×
Fwd P/E: 17.6×
Dividend yield: —
F-score: 8/9
Altman Z: 7.86
Beneish M: −0.88
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	7	7	7	8	+8 more TTM periods Free account
ROE Full definition →	61.42%	66.12%	64.98%	59.91%
ROA Full definition →	46.45%	48.52%	48.54%	44.11%
ROIC Full definition →	42.95%	40.76%	34.24%	30.35%
Return on Tangible Assets Full definition →	63.67%	70.86%	75.37%	71.74%
Average Days of Receivables Full definition →	53.79	48.20	60.17	53.46
Free Cash Flow per Share Full definition →	1.33	1.35	1.26	1.01
Free Cash Flow Full definition →	177.03	175.07	166.64	135.41
Capital Expenditures Full definition →	(0.13)	(0.18)	(0.27)	(0.25)
Other line items
Cash ROIC Full definition →	14.96%	15.89%	16.76%	13.13%
Accounts Receivable Turnover Full definition →	8.23	7.67	6.66	7.26
Accounts Payable Turnover Full definition →	11.54	11.90	8.89	7.69
Inventory Turnover Full definition →	0.68	0.66	0.66	0.77
Average Days of Payables Full definition →	36.47	21.08	31.74	37.02
Days of Inventory on Hand Full definition →	529.11	548.68	553.66	510.54
Tax Rate Full definition →	0.88	0.96	1.23	1.52
Research and Development Expense of Revenue Full definition →	14.93%	12.79%	11.48%	11.48%
Selling, General and Administrative Expense of Revenue Full definition →	30.92%	32.41%	34.69%	35.96%
Share Based Compensation of Revenue Full definition →	4.61%	4.69%	5.77%	5.19%
Interest Coverage Full definition →	37.19	34.25	30.38	26.43
Operating CF/Net income Full definition →	0.56	0.56	0.56	0.47
Depreciation/Fixed assets Full definition →	11.14	10.41	9.77	9.21
Capex/Depreciation Full definition →	(0.01)	(0.01)	(0.01)	(0.01)
Revenue per Share Full definition →	2.41	2.39	2.25	2.11
Operating CF per Share Full definition →	1.33	1.35	1.26	1.01
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly